Common diabetes pill tested to stop mouth cancer before it starts
NCT ID NCT02581137
Summary
This study is testing whether metformin, a common diabetes medication, can help prevent oral cancer in people who have precancerous red or white patches in their mouth. Twenty-six participants with these high-risk lesions will take metformin pills daily for about 3 months. Researchers will check if the patches shrink or disappear and study how the drug affects cells and markers in the mouth, blood, and saliva.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ERYTHROPLAKIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BC Cancer Research Centre
Vancouver, British Columbia, V5Z 1L3, Canada
-
UC San Diego Medical Center - Hillcrest
San Diego, California, 92103, United States
-
University of British Columbia Hospital
Vancouver, British Columbia, V6T 2B5, Canada
-
University of Minnesota/Masonic Cancer Center
Minneapolis, Minnesota, 55455, United States
Conditions
Explore the condition pages connected to this study.